What's Going On With GT Biopharma Stock Tuesday?
What's Going On With GT Biopharma Stock Tuesday?
GT Biopharma (NASDAQ:GTBP) shares rose Tuesday morning before pulling back and turning negative after the company announced a direct offering.
GT Biopharma（纳斯达克股票代码：GTBP）股价周二上午上涨，随后在公司宣布直接发行后回落并转为负值。
The Details: GT Biopharma entered into a definitive securities purchase agreement for the purchase and sale of 740,000 shares of its common stock at a purchase price of $4.35 per share. The shares will be offered in a registered direct offering priced at-the-market under Nasdaq rules. Roth Capital Partners is acting as the exclusive placement agent for the offering.
详情：GT Biopharma签订了最终证券购买协议，以每股4.35美元的收购价购买和出售其74万股普通股。根据纳斯达克的规定，这些股票将以注册直接发行的形式发行，在市场上定价。罗斯资本合伙人是此次发行的独家配售代理。
In a concurrent private placement, the company announced it will issue warrants allowing the purchase of up to 740,000 shares of its common stock. The warrants will be immediately exercisable at a price of $4.35 per share and will be valid for five years from issuance.
在同时进行的私募中，该公司宣布将发行认股权证，允许购买多达74万股普通股。认股权证将立即以每股4.35美元的价格行使，自发行之日起五年内有效。
Before deducting the placement agent's fees and other expenses, the company anticipates raising approximately $3.2 million. GT Biopharma noted that it plans to use the proceeds for general corporate purposes. The offering is expected to close on or about May 23.
在扣除配售代理的费用和其他费用之前，该公司预计将筹集约320万美元。GT Biopharma指出，它计划将所得款项用于一般公司用途。此次发行预计将于5月23日左右结束。
Related Link: AstraZeneca Targets Ambitious $80B In Total Revenue By 2030 Through Pipeline Expansion
相关链接：阿斯利康的目标是通过管道扩张到2030年实现800亿美元的总收入
GTBP Price Action: GT Biopharma shares were halted on the circuit breaker Tuesday morning. The stock was down 22.1% at $6.07 at the time of writing, per Benzinga Pro.
GTBP价格走势：周二上午，GT Biopharma的股票因断路器而暂停。根据Benzinga Pro的数据，在撰写本文时，该股下跌了22.1％，至6.07美元。
Image: 761599 from Pixabay.
图片：来自 Pixabay 的 761599。